Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Umbilical Cord Blood for Poor Graft Function Post-Allo-HSCT
NCT05669079Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules, Hematopoietic Stem Cells
01
Overview
A Phase 3 trial of decitabine, umbilical cord blood in poor graft function (PGF), sponsored by First Affiliated Hospital of Soochow University. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
decitabineumbilical cord blood
03
Conditions
poor graft function (PGF)
Beyond the preview
Go deeper on NCT05669079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05669079.